Heterozygous Mutations in TREX1 Cause Familial Chilblain Lupus and Dominant Aicardi-Goutières Syndrome
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
TREX1 constitutes the major 3'-->5' DNA exonuclease activity measured in mammalian cells. Recently, biallelic mutations in TREX1 have been shown to cause Aicardi-Goutieres syndrome at the AGS1 locus. Interestingly, Aicardi-Goutieres syndrome shows overlap with systemic lupus erythematosus at both clinical and pathological levels. Here, we report a heterozygous TREX1 mutation causing familial chilblain lupus. Additionally, we describe a de novo heterozygous mutation, affecting a critical catalytic residue in TREX1, that results in typical Aicardi-Goutieres syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“TREX1 mutations have been identified in SLE115 and familial chilblain lupus116, implicating TREX1 as a safeguard against autoimmune inflammation.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [116]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type I Interferon in Systemic Lupus Erythematosus and Other Autoimmune Diseases
Banchereau, J., & Pascual, V. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.010 · Cited by 963
Crow, Y. J., Hayward, B. E., Parmar, R., Robins, P., Leitch, A., Ali, M., Black, D. N., van Bokhoven, H., Brunner, H. G., Hamel, B. C., et al. (2006) · Nature Genetics · doi:10.1038/ng1845 · Cited by 903 · cited 5×
“3), comparable to the level seen in cells from unaffected heterozygous parents of subjects with recessive AGS.6 Our previous analyses of AGS-affected patients with biallelic TREX1 mutations indicated that AGS at the AGS1 locus results from an abrogation of TREX1 enzyme activity.6 The TREX1 protein functions as a dimer…”
BackgroundSelf-citationOnline Mendelian Inheritance in Man 'OMIM'.
Amladi, S. (2003) · PubMed · Cited by 875
Crow, Y. J., Leitch, A., Hayward, B. E., Garner, A., Parmar, R., Griffith, E., Ali, M., Semple, C., Aicardi, J., Babul-Hirji, R., et al. (2006) · Nature Genetics · doi:10.1038/ng1842 · Cited by 675
Self-citationMutation of DNASE1 in people with systemic lupus erythematosus
Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M., & Kuroda, Y. (2001) · Nature Genetics · doi:10.1038/91070 · Cited by 596
Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages
Kawane, K., Ohtani, M., Miwa, K., Kizawa, T., Kanbara, Y., Yoshioka, Y., Yoshikawa, H., & Nagata, S. (2006) · Nature · doi:10.1038/nature05245 · Cited by 470 · cited 1×
“Of note in the context of AGS, mutations in DNase I are associated with a lupus phenotype,(22) and mice deficient in DNase II accumulate undigested DNA in macrophages, with consequent IFN-b up-regulation, and recapitulate the clinical and immunological phenotype of rheumatoid arthritis.(23) We have suggested(6) that A…”
BackgroundMorita, M., Stamp, G., Robins, P., Dulic, A., Rosewell, I., Hrivnak, G., Daly, G., Lindahl, T., & Barnes, D. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6719-6727.2004 · Cited by 380 · cited 2×
“Lymphoblastoid cell lines were established from affected individuals, and TREX1 exonuclease activity in cell extracts was measured, as described elsewhere, with use of a polydeoxynucleotide substrate.(3) Extracts of control lymphoblastoid cell lines exhibited readily detected TREX1 activity.”
BackgroundMethodSelf-citationMazur, D. J., & Perrino, F. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19655 · Cited by 276
Self-citationChowdhury, D., Beresford, P. J., Zhu, P., Zhang, D., Sung, J.-S., Demple, B., Perrino, F. W., & Lieberman, J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.005 · Cited by 264
Self-citationA human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein
Hoss, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.13.3868 · Cited by 170 · cited 3×
“Despite its position within the EXO I domain, one of three sequence motifs containing four acidic residues participating in the coordination of divalent metal ions necessary for catalysis—the phenylalanine at position 17—is not conserved in mouse Trex1 or the related human TREX2.”
BackgroundSelf-citation
Cited by
Items 101–200 of 404
Günther, C., Meurer, M., Stein, A., Viehweg, A., & Lee‐Kirsch, M. A. (2009) · Dermatology · doi:10.1159/000222430 · Cited by 58
“Until to date, only 1 additional case of familial chilblain lupus caused by a mutation in the TREX1 gene has been described in a pedigree of Bangladeshi origin [”
BackgroundDiFrancesco, J. C., Novara, F., Zuffardi, O., Forlino, A., Gioia, R., Cossu, F., Bolognesi, M., Andreoni, S., Saracchi, E., Frigeni, B., et al. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1944-9 · Cited by 58
“Different TREX1 mutations have been reported in Aicardi– Goutière syndrome [11], systemic lupus erythematosus [12] and familial chilblain lupus [13].”
BackgroundRole of DNA/RNA sensors and contribution to autoimmunity
Smith, S., & Jefferies, C. A. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.019 · Cited by 61
“These mutations (TREX1D18N, TREX1D200N and TREX1R114H) result in an inability of Trex1 to degrade both ss- and ds-DNA which leads to increased levels of immunostimulatory DNA and a subsequent increase in IFN production which contributes to systemic autoimmunity [2,4,5].”
BackgroundCurrent Insights in Cutaneous Lupus Erythematosus Immunopathogenesis
Garelli, C. J., Refat, M. A., Nanaware, P. P., Ramirez‐Ortiz, Z. G., Rashighi, M., & Richmond, J. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01353 · Cited by 57
Autoimmunity and Primary Immunodeficiency Disorders
Allenspach, E. J., & Torgerson, T. R. (2016) · Journal of Clinical Immunology · doi:10.1007/s10875-016-0294-1 · Cited by 57
“lupus called Chilblain lupus [11–13].”
Niewold, T. B. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000205 · Cited by 61
“Mutations in TREX1 have also been reported in the clinical syndromes familial chilblain lupus [49] and retinal vasculopathy with cerebral leukodystrophy [50].”
BackgroundWang, X., Wang, Y., Cao, A., Luo, Q., Chen, D., Zhao, W., Xu, J., Li, Q., Bu, X., & Quan, J. (2023) · Nature Communications · doi:10.1038/s41467-023-41892-5 · Cited by 58
“degrading cytosolicDNA, leadto the accumulation of cytosolic dsDNA and aberrant activation of cGAS-STING pathway, subsequently trigger autoimmune diseases 25,26 , such as Aicardi-Goutières syndrome (AGS) 27,28 or chilblain lupus 29 and systemic lupus erythematosus (SLE) 30,31 .”
Miyazaki, T., Kim, Y.-S., Yoon, J., Wang, H., Suzuki, T., & Morse, H. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.547331 · Cited by 63
“Familial chilblain lupus, an inherited cutaneous form of SLE caused by dominant mutations in TREX1, is not associated with neurological manifestations, but there is some overlap with AGS as some AGS patients develop chilblains and autoantibodies (8, 9).”
BackgroundPseudoviral immunity – a novel concept for lupus
Anders, H. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.10.004 · Cited by 60
Genetics and molecular biology of brain calcification
Deng, H., Zheng, W. L., & Jankovic, J. J. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.04.004 · Cited by 57
“In 2012, Rice et al. (2012) identified homozygous or compound eterozygous mutations (p.”
BackgroundThe Exonuclease Trex1 Restrains Macrophage Proinflammatory Activation
Pereira-Lopes, S., Celhar, T., Sans-Fons, G., Serra, M., Fairhurst, A.-M., Lloberas, J., & Celada, A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301603 · Cited by 53
“Such mutations are also associated with familial chilblain lupus (7) and with systemic lupus erythematosus (SLE), both of which have partial symptom overlap with AGS phenotype (8).”
BackgroundAicardi–Goutières syndrome harbours abundant systemic and brain-reactive autoantibodies
Cuadrado, E., Vanderver, A. L., Brown, K. J., Sandza, A., Takanohashi, A., Jansen, M. H., Anink, J. J., Herron, B. M., Orcesi, S., Olivieri, I., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205396 · Cited by 55
Self-citationGenes involved in leukodystrophies: A glance at glial functions
Boespflug‐Tanguy, O., Labauge, P. M., Fogli, A., & Vaurs‐Barrière, C. (2008) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-008-0034-x · Cited by 56
Type I interferonopathies—an expanding disease spectrum of immunodysregulation
Lee‐Kirsch, M. A., Wolf, C., Kretschmer, S., & Roers, A. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0500-x · Cited by 60
TREX1 – Apex predator of cytosolic DNA metabolism
Simpson, S. R., Hemphill, W. O., Hudson, T., & Perrino, F. W. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102894 · Cited by 58
“In contrast, humans expressing catalytically inactive TREX1 D18N develop less severe autosomal dominant Familial Chilblain Lupus (FCL) [8,57,58].”
BackgroundInfluentialSelf-citationCutaneous histopathological findings of Aicardi–Goutières syndrome, overlap with chilblain lupus
Kolivras, A., Aeby, A., Crow, Y. J., Rice, G., Saß, U., & André, J. (2008) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2007.00900.x · Cited by 51
“recently reported that a gene for familial chilblain lupus (FCL) mapped to chromosome 3p21, and subsequently, Rice et al.(32) have shown that AGS and FCL are allelic disorders by showing heterozygous TREX1 mutations in an FCL family.”
BackgroundSelf-citationExpanding the B Cell-Centric View of Systemic Lupus Erythematosus
Morawski, P. A., & Bolland, S. M. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.02.001 · Cited by 57
“mutations in exonucleases like TREX1, which degrade reverse-transcribed DNA retroelements, and results in an IFNassociated disease in humans [10].”
BackgroundMonogenic Autoinflammatory Diseases: State of the Art and Future Perspectives
Donato, G. D., d’Angelo, D. M., Breda, L., & Chiarelli, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126360 · Cited by 56
Deregulated Type I IFN Response in TREX1-Associated Familial Chilblain Lupus
Peschke, K., Friebe, F., Zimmermann, N., Wahlicht, T., Schumann, T., Achleitner, M., Berndt, N., Luksch, H., Behrendt, R., Lee‐Kirsch, M. A., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.496 · Cited by 53
Genetics of SLE: Functional Relevance for Monocytes/Macrophages in Disease
Byrne, J. C., Gabhann, J. N., Lazzari, E., Mahony, R., Smith, S., Stacey, K., Wynne, C., & Jefferies, C. A. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/582352 · Cited by 57
Familial Chilblain Lupus - What Can We Learn from Type I Interferonopathies?
Fiehn, C. (2017) · Current Rheumatology Reports · doi:10.1007/s11926-017-0689-x · Cited by 53
SAMHD1: Recurring roles in cell cycle, viral restriction, cancer, and innate immunity
Mauney, C. H., & Hollis, T. (2018) · Autoimmunity · doi:10.1080/08916934.2018.1454912 · Cited by 64
Self-citationShaban, N. M., Harvey, S., Perrino, F. W., & Hollis, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.059048 · Cited by 52
Self-citationA de novo p.Asp18Asn mutation in TREX1 in a patient with Aicardi–Goutières syndrome
Haaxma, C. A., Crow, Y. J., Steensel, M. A. M. V., Lammens, M. M. Y., Rice, G., Verbeek, M. M., & Willemsen, M. A. A. P. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33620 · Cited by 49
“However, both IFN-alpha and neopterin levels in CSF are known to vary during the course of recessive AGS and may fall to normal after the first few years of life, while pleocytosis rarely persists beyond the first year [Rice et al., 2007b; Crow and Livingston, 2008].”
BackgroundSelf-citationSanta, P., Garreau, A., Serpas, L., Ferrière, A., Blanco, P., Soni, C., & Sisirak, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.629922 · Cited by 71
“AGS is an inflammatory syndrome characterized by an encephalitis accompanied by lymphocyte infiltration in the central nervous system and an IFN-I signature (124).”
BackgroundInfluentialAicardi–Goutieres syndrome: from patients to genes and beyond
Chahwan, C., & Chahwan, R. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01825.x · Cited by 53
“In fact, even de novo heterozygous mutations in TREX1 (D18N and D200N) (30, 39) and autosomal-dominant heterozygous mutations in SAMHD1 (I201N) (37) have been associated with FCL, which suggest that these proteins might homo-polymerize rendering a single mutation in one allele to become dominant negative.”
BackgroundType I Interferonopathies: from a Novel Concept to Targeted Therapeutics
Melki, I., & Frémond, M. (2020) · Current Rheumatology Reports · doi:10.1007/s11926-020-00909-4 · Cited by 54
Relapsing polychondritis: clinical updates and new differential diagnoses
Mertz, P., Costedoat-Chalumeau, N., Ferrada, M. A., Moulis, G., MEKINIAN, A., Grayson, P. C., & Arnaud, L. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01113-9 · Cited by 52
“In this condition, cold-induced painful bluish-red lesions typically affect the fingers and toes but involvement of the ear pinna and of the nose has also been reported 84 .”
Tüngler, V., Silver, R. M., Walkenhorst, H., Günther, C., & Lee‐Kirsch, M. A. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10813.x · Cited by 50
Developments in the clinical understanding of lupus
Crow, M. K. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2762 · Cited by 53
“In addition to the GWAS, which identify common genetic variants, old observations of the high risk of SLE in rare patients with C2, C4 and C1q deficiencies have now been supplemented with data from several groups identifying lupus in patients with mutations in a DNase encoded by TREX1 [ 23 ].”
BackgroundMethodHERC5-catalyzed ISGylation potentiates cGAS-mediated innate immunity
Chu, L., Qian, L., Chen, Y., Duan, S., Ding, M., Sun, W., Meng, W., Zhu, J., Wang, Q., Hao, H., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113870 · Cited by 50
Orebaugh, C. D., Fye, J. M., Harvey, S. E., Hollis, T., & Perrino, F. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.297903 · Cited by 54
Self-citationHuman DNA Exonuclease TREX1 Is Also an Exoribonuclease That Acts on Single-stranded RNA
Yuan, F., Dutta, T., Wang, L., Song, L., Gu, L., Qian, L., Benitez, A., Ning, S., Malhotra, A., Deutscher, M. P., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.653915 · Cited by 44
Astrocytes, an active player in Aicardi–Goutières syndrome
Sase, S., Takanohashi, A., Vanderver, A., & Almad, A. (2018) · Brain Pathology · doi:10.1111/bpa.12600 · Cited by 45
“TREX1 mutations causing AGS are generally autosomal recessive (62); however, there are reports of autosomal dominant heterozygous TREX1 mutations (62).”
BackgroundRoelofs, M. F., Abdollahi‐Roodsaz, S., Joosten, L. A. B., van den Berg, W. B., & Radstake, T. R. D. J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23217 · Cited by 51
Damsky, W., Peterson, D. M., & King, B. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.06.052 · Cited by 43
Inborn Errors of Immunity and Autoimmune Disease
Gray, P. E., & David, C. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.04.018 · Cited by 51
How common are single gene mutations as a cause for lacunar stroke? A targeted gene panel study
Tan, R. Y. Y., Traylor, M., Mégy, K., Duarte, D., Deevi, S. V. V., Shamardina, O., Mapeta, R. P., Ouwehand, W. H., Gräf, S., Downes, K., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008544 · Cited by 49
“Missense TREX1 variants are also associated with Aicardi-Goutières syndrome,(28) a form of pediatric-onset encephalopathy, and familial chilblain lupus.(29) Three novel missense variants (p.”
BackgroundThe TREX1 C-terminal Region Controls Cellular Localization through Ubiquitination
Orebaugh, C. D., Fye, J. M., Harvey, S. E., Hollis, T., Wilkinson, J. C., & Perrino, F. W. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.503391 · Cited by 53
“Exonuclease Activities of AGS and SLE TREX1 Mutants— Approximately 40 TREX1 mutations have been identified in a spectrum of related autoimmune diseases, and we previously demonstrated the extremely broad range of catalytic activities exhibited among TREX1 mutants that yield similar human pathologies (10, 19, 22, 25).”
BackgroundSelf-citationGenetic interferonopathies: An overview
Eleftheriou, D., & Brogan, P. A. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2017.12.002 · Cited by 46
Aicardi‐Goutières syndrome: description of a late onset case
D’Arrigo, S., Riva, D., Bulgheroni, S., Chiapparini, L., Lebon, P., Rice, G., Crow, Y. J., & Pantaleoni, C. (2008) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2008.03033.x · Cited by 41
“Heterozygous mutations in TREX1 ⁄ AGS1 have been described to cause familial chilblain lupus.(10) The reported family history suggests that individuals heterozygous for AGS2–4 mutations may also demonstrate a monogenic form of chilblain lupus, an observation that warrants further investigation.”
BackgroundSelf-citationPernicious anemia – Genetic insights
Banka, S., Ryan, K. E., Thomson, W., & Newman, W. G. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.01.009 · Cited by 43
Self-citationEarly onset of autoimmune disease by the retroviral integrase inhibitor raltegravir
Beck-Engeser, G. B., Eilat, D., Harrer, T., Jäck, H.-M., & Wabl, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908074106 · Cited by 40
“That these elements may contribute to autoimmune disease is indicated by the fact that human patients with a deficiency in Trex1, an enzyme that degrades retroelement cDNA (1), may suffer from chilblain lupus (2, 3), systemic lupus erythematosus (4), or Aicardi-Goutières syndrome (2, 3, 5).”
BackgroundAbe, J., Izawa, K., Nishikomori, R., Awaya, T., Kawai, T., Yasumi, T., Hiragi, N., Hiragi, T., Ohshima, Y., & Heike, T. (2012) · Rheumatology · doi:10.1093/rheumatology/kes181 · Cited by 48
Endogenous retroelements and autoimmune disease
Stetson, D. B. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.09.007 · Cited by 44
DNA repair and systemic lupus erythematosus
Meas, R., Burak, M. J., & Sweasy, J. B. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.06.020 · Cited by 42
Perillaldehyde Inhibition of cGAS Reduces dsDNA-Induced Interferon Response
Chu, L., Li, C., Li, Y., Yu, Q., Yu, H., Li, C., Meng, W., Zhu, J., Wang, Q., Wang, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.655637 · Cited by 41
“Loss-of-function mutations in Trex1 have been identified in autoimmune disorders such as Aicardi– Goutières syndrome (AGS) and familial chilblain lupus in human patients (9, 10).”
BackgroundChilblains as a Diagnostic Sign of Aicardi-Goutières Syndrome
Abdel‐Salam, G. M. H., El‐Kamah, G. Y., Rice, G., El‐Darouti, M., Gornall, H., Szynkiewicz, M., AYMARD, F., Zaki, M. S., Aleem, A. K. A., Lebon, P., et al. (2010) · Neuropediatrics · doi:10.1055/s-0030-1255059 · Cited by 39
Self-citationNucleic acid‐mediated inflammatory diseases
Rigby, R. E., Leitch, A., & Jackson, A. P. (2008) · BioEssays · doi:10.1002/bies.20808 · Cited by 38
“TREX1 and autoimmune disease Heterozygous mutations in TREX1 (in contrast to the bialleic mutations found in AGS) have been identified as causing familial chilblain lupus.((15,63)) Familial chilblain lupus, thought to be a subtype of SLE, is characterised by ulcerating acral skin lesions, associated with arthralgia an…”
BackgroundTwo further cases of spondyloenchondrodysplasia (SPENCD) with immune dysregulation
Navarro, V., Scott, C., Briggs, T. A., Barète, S., Francès, C., Lebon, P., Maisonobe, T., Rice, G., Wouters, C. H., & Crow, Y. J. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32518 · Cited by 38
“…et al., 2000; De Laet et al., 2005; Rasmussen et al., 2005], and the recent identification of TREX1/AGS1 mutations in SLE [Lee-Kirsch et al., 2007] and familial chilblain lupus [Rice et al., 2007b], we are intrigued by the observation of a raised level of interferon-alpha in the serum of Patient 1.”
BackgroundSelf-citationGiaglis, S., Daoudlarian, D., Voll, R. E., Kyburz, D., Venhoff, N., & Walker, U. A. (2021) · RMD Open · doi:10.1136/rmdopen-2021-002010 · Cited by 44
Abe, J., Nakamura, K., Nishikomori, R., Kato, M., Mitsuiki, N., Izawa, K., Awaya, T., Kawai, T., Yasumi, T., Toyoshima, I., et al. (2013) · Rheumatology · doi:10.1093/rheumatology/ket372 · Cited by 43
Kumar, S., Morrison, J. H., Dingli, D., & Poeschla, E. M. (2018) · Journal of Virology · doi:10.1128/jvi.00001-18 · Cited by 42
“For example, while most AGS-associated TREX1 mutations are autosomal recessive and result in loss of exonuclease activity, most SLE-associated mutant TREX1 proteins are autosomal dominant and do not affect DNase activity (17, 18).”
BackgroundMechanistic link between DNA damage sensing, repairing and signaling factors and immune signaling
Mukherjee, S., Abdisalaam, S., Bhattacharya, S., Kalayarasan, S., Sinha, D., & Asaithamby, A. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.11.004 · Cited by 41
“Mutations in human TREX1 cause a spectrum of autoimmune disorders, including Aicardi–Goutieres syndrome, familial chilblain lupus and retinal vasculopathy with cerebral leukodystrophy, and are associated with systemic lupus erythematosus (DiFrancesco et al., 2015; Lee-Kirsch, Wolf, & Gunther, 2014; Rice et al., 2007).”
BackgroundmiR-23a/b suppress cGAS-mediated innate and autoimmunity
Yu, Q., Chu, L., Li, Y., Wang, Q., Zhu, J., Wang, C., & Cui, S. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00668-x · Cited by 37
“Loss-of-function mutations in TREX1, a DNA 3' repair exonuclease that degrades cytosolic DNA, have been identified in autoimmune disorders such as Aicardi–Goutières syndrome (AGS) and familial chilblain lupus in human patients.(8,9) Trex1 mice exhibit autoimmune responses similar to those of AGS patients and are a tra…”
BackgroundTyping TREX1 gene in patients with systemic lupus erythematosus
Fredi, M., Bianchi, M., Andréoli, L., Greco, G., Olivieri, I., Orcesi, S., Fazzi, E. M., Cereda, C., & Tincani, A. (2015) · Reumatismo · doi:10.4081/reumatismo.2015.782 · Cited by 46
TREX1 acts in degrading damaged DNA from drug-treated tumor cells
Wang, C.-J., Lam, W., Bussom, S., Chang, H.-M., & Cheng, Y. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.06.006 · Cited by 36
Inherited Autoinflammatory Syndromes
Rood, J. E., & Behrens, E. M. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-030121-041528 · Cited by 39
Douville, R. N., & Hiscott, J. B. (2010) · Cytokine · doi:10.1016/j.cyto.2010.04.010 · Cited by 39
Imaging Manifestations of the Leukodystrophies, Inherited Disorders of White Matter
Yang, E., & Prabhu, S. P. (2014) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2013.11.008 · Cited by 37
Innate immune processes in lupus erythematosus
Aringer, M., Günther, C., & Lee‐Kirsch, M. A. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.11.012 · Cited by 37
Cutaneous Lupus Erythematosus: Current and Future Pathogenesis-Directed Therapies.
Little, A. J., & Vesely, M. D. (2020) · PubMed Central · Cited by 51
RNaseH2 mutants that cause Aicardi–Goutieres syndrome are active nucleases
Perrino, F. W., Harvey, S., Shaban, N. M., & Hollis, T. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0422-3 · Cited by 35
“These genetic defects in AGS are mostly inherited as recessive alleles, but dominant alleles have also been reported [11].”
Self-citationImmunogenetics of cutaneous lupus erythematosus
Hersh, A. O., Arkin, L. M., & Prahalad, S. (2016) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000383 · Cited by 34
“Mutations in the Three Prime Repair Exonuclease 1(TREX1) gene are associated with a rare form of CLE called familial chilblain lupus [34].”
BackgroundThe DNA damage induced immune response: Implications for cancer therapy
Barros, E. M., McIntosh, S., & Savage, K. I. (2022) · DNA repair · doi:10.1016/j.dnarep.2022.103409 · Cited by 40
Tomicic, M. T., Aasland, D., Nikolova, T., Kaina, B., & Christmann, M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.03.029 · Cited by 35
“Mutations in TREX1 are associated with the Aicardi–Goutières syndrome [4,5], autosomal dominant retinal vasculopathy with cerebral leukodystrophy [6], systemic lupus erythematosus [7] and familial chilblain lupus [8].”
BackgroundSoong, B., Liao, Y., Tu, P., Tsai, P., Lee, I., Chung, C., & Lee, Y. (2013) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2013.03.002 · Cited by 35
White, T. E., Brandariz-Núñez, A., Martínez‐López, A., Knowlton, C., Lenzi, G. M., Kim, B., Ivanov, D. N., & Diaz‐Griffero, F. (2017) · Human Mutation · doi:10.1002/humu.23201 · Cited by 37
“…linked to AGS have been shown to cause increased cellular nucleic acid levels and activate the innate immune response (Crow et al., 2006; Fye, Orebaugh, Coffin, Hollis, & Perrino, 2011; Orebaugh, Fye, Harvey, Hollis, & Perrino, 2011; Rice et al., 2007; Rice et al., 2013; Stetson et al., 2008).”
BackgroundVogt, J., Agrawal, S., Ibrahim, Z., Southwood, T. R., Philip, S., MacPherson, L. K. R., Bhole, M. V., Crow, Y. J., & Oley, C. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35712 · Cited by 39
“Mutations inRNASEH2B and SAMHD1 are nowwell recognized to sometimes result in relatively mild variants of the AGS phenotype, with later onset, better intellectual preservation and enhanced survival [Rice et al., 2007b, 2009; Ramantani et al., 2010].”
BackgroundSelf-citationThe evolving genetic landscape of congenital disorders of glycosylation
Wilson, M. P., & Matthijs, G. (2021) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2021.129976 · Cited by 35
Genetics of migraine: an update with special attention to genetic comorbidity
Stam, A. H., van den Maagdenberg, A. M. J. M., Haan, J., Terwindt, G. M., & Ferrari, M. D. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282fd171a · Cited by 39
Vicious circle: systemic autoreactivity in Ro52/TRIM21-deficient mice
Bolland, S. M., & García‐Sastre, A. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20091507 · Cited by 37
“It is still unclear how the epitope spreading occurs, although various pathways have been invoked that may act at various stages of linked to autoimmune susceptibility (Crow et al., 2006; Rice et al., 2007, 2009; Stetson et al., 2008).”
BackgroundWei, X., Wang, Z., Hinson, C. M., & Yang, K. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac185 · Cited by 34
“TREX1 mutations cause several human autoimmune diseases, such as Aicardi-Goutieres syndrome and familial chilblain lupus (81,82).”
cGAS in nucleus: The link between immune response and DNA damage repair
Song, J.-X., Villagomes, D., Zhao, H., & Zhu, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1076784 · Cited by 36
Brucet, M., Querol‐Audí, J., Bertlik, K., Lloberas, J., Fita, I., & Celada, A. (2008) · Protein Science · doi:10.1110/ps.036426.108 · Cited by 37
“…directly involved in a severe neurological brain disease, the Aicardi-Goutières syndrome (Crow et al. 2006), an autosomal dominant retinal vasculopathy with cerebral leukodystrophy (Richards et al. 2007), and is related to systemic lupus erythematosus (Lee-Kirsch et al. 2007a,b; Rice et al. 2007).”
BackgroundConnections between antiviral defense and autoimmunity
Stetson, D. B. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.005 · Cited by 35
“First, dominant mutations in the catalytic domains of Trex1 cause familial chilblain lupus (FCL), a cutaneous form of systemic lupus erythematosus characterized by lesions at the extremities of fingers, toes, and ears [50,51].”
BackgroundBailey, S. L., Harvey, S. E., Perrino, F. W., & Hollis, T. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.10.007 · Cited by 36
Self-citationLupus: How much “complexity” is really (just) genetic heterogeneity?
Crow, Y. J. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30603 · Cited by 31
Self-citationTherapeutic Approaches to Type I Interferonopathies
Bienias, M., Brück, N., Griep, C., Wolf, C., Kretschmer, S., Kind, B., Tüngler, V., Berner, R., & Lee‐Kirsch, M. A. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0743-3 · Cited by 30
Crucial Roles of RSAD2/viperin in Immunomodulation, Mitochondrial Metabolism and Autoimmune Diseases
Chen, S., Ye, J., Lin, Y., Chen, W., Huang, S., Yang, Q., Qian, H., Gao, S., & Hua, C. (2024) · Inflammation · doi:10.1007/s10753-024-02076-5 · Cited by 31
“Notably, under the circumstances of increased ISG expression, several AGS patients are susceptible to developing SLE in early childhood [98–100].”
Dell’Isola, G. B., Dini, G., Culpepper, K., Portwood, K. E., Ferrara, P., Cara, G. D., Verrotti, A., & Lodolo, M. (2023) · World Journal of Pediatrics · doi:10.1007/s12519-022-00679-2 · Cited by 32
“TREX1 and SAMHD1 mutations have been associated with cases of familial chilblain lupus [45, 46].”
BackgroundRegulation of cGAS-STING pathway - Implications for systemic lupus erythematosus
Hagiwara, A. M., Moore, R. E., Wallace, D. J., ISHIMORI, M. L., & Jefferies, C. A. (2021) · Rheumatology and Immunology Research · doi:10.2478/rir-2021-0023 · Cited by 31
Chauvin, S. D., Ando, S., Holley, J. A., Sugie, A., Zhao, F. R., Poddar, S., Kato, R., Miner, C. A., Nitta, Y., Krishnamurthy, S. R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49066-7 · Cited by 31
“We thank the reviewers for the positive assessment of our manuscript.”
TREX1 As a Potential Therapeutic Target for Autoimmune and Inflammatory Diseases
Tao, S., Wu, G., Zhang, Q., Zhang, T., Leng, R., Pan, H., & Ye, D. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190902113218 · Cited by 28
Arkin, L. M., Moon, J. J., Tran, J. M., Asgari, S., O’Farrelly, C., Casanova, J., Cowen, E. W., Mays, J. W., Singh, A. M., Drolet, B. A., et al. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.05.024 · Cited by 27
Removal of TREX1 activity enhances CRISPR–Cas9-mediated homologous recombination
Karasu, M. E., Toufektchan, E., Chen, Y., Albertelli, A., Cullot, G., Maciejowski, J., & Corn, J. E. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02356-3 · Cited by 32
“Mutations associated with TREX1 lead to auto-immune disorders, such as Aicardi–Goutières syndrome 29–31 .”
Arthrogryposes (Multiple Congenital Contractures)
Hall, J. G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00168-3 · Cited by 29
Insights Gained From the Study of Pediatric Systemic Lupus Erythematosus
Lo, M. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01278 · Cited by 27
“Both FCL and AGS have been associated with defects in TREX1, among other genes (49, 50).”
BackgroundEtiology and Pathogenesis of Systemic Lupus Erythematosus
Crow, M. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00079-6 · Cited by 31
TREX1 variants in Sjogren's syndrome related lymphomagenesis
Nezos, A., Makri, P., Gandolfo, S., Vita, S. D., Voulgarelis, M., Crow, M. K., & Mavragani, C. P. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154781 · Cited by 27
TREX1 plays multiple roles in human diseases
Wang, Q., Du, J., Hua, S., & Zhao, K. (2022) · Cellular Immunology · doi:10.1016/j.cellimm.2022.104527 · Cited by 31
Tocilizumab reverses cerebral vasculopathy in a patient with homozygous SAMHD1 mutation
Henrickson, M., & Wang, H. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3600-2 · Cited by 26
“Further, AGS associated with heterozygous TREX1 mutations involves ulcerating acral skin lesions suggestive of chilblain lupus (lupus pernio) [8].”
BackgroundPrendiville, J., & Crow, Y. J. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.05.002 · Cited by 25
“Heterozygous TREX1 mutations have also been identified in pedigrees segregating familial chilblain LE.(7) In addition, heterozygous TREX1 mutations are reported in SLE,(8) making TREX1 mutations the most common monogenic cause of LE yet identified.”
BackgroundSelf-citationIntracellular virus sensor MDA5 mutation develops autoimmune myocarditis and nephritis
Ohto, T., Tayeh, A. A., Nishikomori, R., Abe, H., Hashimoto, K., Baba, S., Arias-Loza, P.-A., Soda, N., Satoh, S., Matsuda, M., et al. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102794 · Cited by 27
Spontaneous activation of RNA-sensing pathways in autoimmune disease
Crampton, S. P., & Bolland, S. M. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.09.011 · Cited by 24
Aicardi–Goutières syndrome: clues from the RNase H2 knock-out mouse
Rabe, B. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1061-x · Cited by 30
Banka, S., Cain, S. A., Carim, S. C., Daly, S. B., Urquhart, J. E., Erdem, G., Harris, J., Bottomley, M., Donnai, D., Kerr, B. A., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204309 · Cited by 25
Self-citationA TREX1 mutation causing cerebral vasculopathy in a patient with familial chilblain lupus
Yamashiro, K., Tanaka, R., Li, Y., Mikasa, M., & Hattori, N. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7084-y · Cited by 24
“[3, 4].”
BackgroundHunter, J. M., Kiefer, J., Balak, C. D., Jooma, S., Ahearn, M. E., Hall, J. G., & Baumbach-Reardon, L. L. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36934 · Cited by 26
“An affected 47XXY male was reported by [Hopkins et al., 1979]However, non-X-linked formsof thedisorderhavebeen reported and the genes are part of a cyclin-dependent kinase-like 5 (Cdkl5) signaling cascade [Crow et al., 2006a; Crow et al., 2006b; Rice et al., 2007; Nemos et al., 2009].”
BackgroundTREX1 Mutation Causing Autosomal Dominant Thrombotic Microangiopathy and CKD—A Novel Presentation
Gulati, A., Bale, A. E., Dykas, D. J., BIA, M. J., Danovitch, G. M., Moeckel, G. W., Somlo, S., & Dahl, N. K. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.05.006 · Cited by 26
Metadata
- Authors
- Rice, G., Newman, W. G., Dean, J., Patrick, T., Parmar, R., Flintoff, K., Robins, P., Harvey, S., Hollis, T., O’Hara, A., Herrick, A. L., Bowden, A. P., Perrino, F. W., Lindahl, T., Barnes, D. E., & Crow, Y. J.
- Affiliations
- St James's University Hospital (GB)
- St Mary's Hospital (GB)
- National Health Service (GB)
- Cancer Research UK (GB)
- Wake Forest University Health Sciences (US)
- Royal Aberdeen Children's Hospital (GB)
- Salford Royal Hospital (GB)
- Rochdale Infirmary (GB)
- Corresponding author
- Crow, Yanick J.
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 80
- Issue
- 4
- Pages
- 811-815
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1852703
- OpenAlex
- W2171946670
- Cited by
- 410
- References
- 24
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 37 · 2023: 13 · 2022: 22 · 2021: 31 · 2020: 19 · 2019: 17 · 2018: 15 · 2017: 20 · 2016: 19 · 2015: 25 · 2014: 26 · 2013: 31 · 2012: 28
- FWCI
- 15.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2301 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM069962, GM 069962)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- TREX1, chilblain lupus, Aicardi-Goutières syndrome, heterozygous mutation, de novo mutations, 3'-5' exonuclease, systemic lupus erythematosus, autoinflammatory disease, catalytic residues
- MeSH terms
- Basal Ganglia Diseases, Base Sequence, Cell Line, Exodeoxyribonucleases, Female, Humans, Lupus Erythematosus, Systemic, Male, Molecular Sequence Data, Mutation, Pedigree, Phosphoproteins, Syndrome, Sequence Analysis, DNA, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.